AMT is quite unique among major Japanese domestic law firms because we are able to offer complete coverage of IP-related services, from patent and trademark prosecution to technology transactions (e.g., license agreements, joint development agreements, and material transfer agreement), infringement and validity opinion works, and litigation/arbitration. We have attorneys-at-law (bengoshi) partners and special counsels who have a strong focus on this practice area. Additionally, we have patent attorneys (benrishi) who have the requisite technical background and are specialized in patent prosecution work in the life sciences area. We, therefore are able to provide one-stop legal services covering both legal and technology aspects through the collaborations between attorneys-at-laws and patent attorneys.

AMT handles finance and corporate transactions, including due diligence investigations, both as part of standalone health care, pharmaceutical and life sciences transactions, and as part of larger M&A transactions. Our practice also covers licensing, sale and purchase of product lines and other transactions peculiar to a life science field. Our life sciences attorneys are engaged in proactively assisting clients in the drafting and negotiation of contracts, taking into consideration the uniqueness of the health care, pharmaceutical and life sciences industries and the nuances of Japanese practice.

■ Digital Health AMT provides a wide variety of advice in the field of digital health, which utilities cutting edge technology. Examples of this field include medical devices that use artificial intelligence (AI), software as a medical device (SaMD) for smart phones, and on-line medical consultations at medical institutions. ■Deep Knowledge in the Field of Regenerative Medicine AMT provides advice on the laws relating to regenerative medicine, such as the Act on Securing Quality, Efficacy and Safety of Products Including Pharmaceutical and Medical Devices, as well as the Act on Securing Safety of Regenerative Medicine, etc. We have also drafted numerous contracts relating to cell processing agreements, and have deep knowledge in the field of regenerative medicine.

Anderson Mori & Tomotsune has a long history of advising international and Japanese health care and life sciences clients on IP acquisition and utilization. We also provide advice in other substantive legal areas, including pharmaceutical regulations (e.g., the Pharmaceutical and Medical Device Act and the Chemical Substances Act). We also conduct due diligence investigations both as part of stand-alone health care and life sciences transactions and as part of larger M&A transactions. Our health care and life sciences attorneys are engaged in proactively assisting clients in the drafting and negotiation of contracts, taking into consideration the uniqueness of the health care and life sciences industries and the nuances of Japanese practice.

■Ongoing Support in Complying with Various Regulations Ｗe have assisted our clients in connection with their various regulatory needs, including, without limitation, regulatory advice on pharmaceutical regulations, such as the Act on Securing Quality, Efficacy and Safety of Products Including Pharmaceutical and Medical Devices, as well as various regulations regarding advertising and labeling, such as the Fair Competition Code, the Act against Unjustifiable Premiums and Misleading Representations, the Health Promotion Act and the Food Labeling Act. ■ Responding to Compliance Violations and Investigations Our firm, whose members include former prosecutors, responds when compliance violations are discovered within our clients or when investigations are conducted by the authorities. Depending on the situation, such responses may include conducting internal investigations within the client, conducting independent investigations by third party committees, and dealing with the authorities.